Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15501-15550 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
N/AActive, not recruiting
64 participants
Started: Jul 16, 2019 · Completed: Mar 7, 2026
54 conditions1 sponsor144 locations
NCT03761498
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
N/AActive, not recruiting
118 participants
Started: Jul 15, 2019 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT03772743
Functional Assessment in Elderly MI Patients with Multivessel Disease
NAActive, not recruiting
1,445 participants
Started: Jul 15, 2019 · Completed: Oct 3, 2026
1 condition1 sponsor37 locations
NCT03926299
Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus
NAActive, not recruiting
66 participants
Started: Jul 15, 2019 · Completed: Jul 30, 2024
2 conditions1 sponsor1 location
NCT03915444
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma
PHASE2Active, not recruiting
42 participants
Started: Jul 15, 2019 · Completed: Jul 31, 2023
1 condition2 sponsors4 locations
NCT04094298
Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease
PHASE3Active, not recruiting
65 participants
Started: Jul 15, 2019 · Completed: Jan 31, 2025
5 conditions1 sponsor1 location
NCT03942770
Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2
NAActive, not recruiting
91 participants
Started: Jul 15, 2019 · Completed: Dec 1, 2026
1 condition2 sponsors2 locations
NCT04022213
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum
PHASE2Active, not recruiting
31 participants
Started: Jul 15, 2019 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT03730792
Success & Health Impacts For Transit Drivers During Onboarding
NAActive, not recruiting
284 participants
Started: Jul 15, 2019 · Completed: Jul 31, 2024
1 condition2 sponsors1 location
NCT04019522
American Heart Association- Stroke/Hypoxia Study
NAActive, not recruiting
12 participants
Started: Jul 15, 2019 · Completed: Mar 1, 2024
1 condition1 sponsor1 location
NCT04461808
Tomosynthesis as Primary Test for Breast Cancer Screening
NAActive, not recruiting
10,156 participants
Started: Jul 15, 2019 · Completed: Apr 30, 2029
1 condition4 sponsors4 locations
NCT04066556
SMART-EST(Specialized Multi-center Attributed Registry of sTroke - EndovaScular or Thrombolytic Therapy)
N/AActive, not recruiting
5,000 participants
Started: Jul 12, 2019 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT03598842
Tuberculosis - Learning the Impact of Nutrition
NAActive, not recruiting
786 participants
Started: Jul 12, 2019 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT04018391
Task Shifting to Treat Depression and HIV Medication Nonadherence in Low Resource Settings
NAActive, not recruiting
280 participants
Started: Jul 12, 2019 · Completed: Mar 31, 2025
2 conditions4 sponsors1 location
NCT03807531
A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee
NAActive, not recruiting
100 participants
Started: Jul 11, 2019 · Completed: Jun 1, 2028
1 condition2 sponsors6 locations
NCT03945721
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients
PHASE1Active, not recruiting
21 participants
Started: Jul 11, 2019 · Completed: Dec 31, 2028
2 conditions2 sponsors2 locations
NCT04019327
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Jul 11, 2019 · Completed: Jul 31, 2027
5 conditions1 sponsor9 locations
NCT04012151
Arm and Finger Measurement for Blood Pressure Surveillance
N/AActive, not recruiting
300 participants
Started: Jul 10, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03912064
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
PHASE1Active, not recruiting
25 participants
Started: Jul 10, 2019 · Completed: Dec 31, 2026
5 conditions2 sponsors2 locations
NCT03815656
Closed Loop DBS Implanted RC+S Study
NAActive, not recruiting
6 participants
Started: Jul 10, 2019 · Completed: Jan 31, 2027
1 condition4 sponsors1 location
NCT03874884
177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
PHASE1Active, not recruiting
70 participants
Started: Jul 9, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT04175041
A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC
NAActive, not recruiting
104 participants
Started: Jul 9, 2019 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT03933826
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
N/AActive, not recruiting
570 participants
Started: Jul 9, 2019 · Completed: Jun 30, 2029
3 conditions2 sponsors36 locations
NCT03974022
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation (WU-KONG1)
PHASE1/PHASE2Active, not recruiting
315 participants
Started: Jul 9, 2019 · Completed: Jul 31, 2025
1 condition1 sponsor124 locations
NCT04042402
Long Term Extension Study in Patients With Primary Hyperoxaluria
PHASE3Active, not recruiting
75 participants
Started: Jul 9, 2019 · Completed: Apr 1, 2030
6 conditions1 sponsor23 locations
NCT04071964
Gut Microbiota, Anastomotic Leak and Colorectal Cancer
N/AActive, not recruiting
300 participants
Started: Jul 9, 2019 · Completed: Jul 9, 2025
1 condition1 sponsor1 location
NCT03873467
Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)
NAActive, not recruiting
65 participants
Started: Jul 8, 2019 · Completed: Dec 30, 2026
1 condition2 sponsors1 location
NCT03570632
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
PHASE4Active, not recruiting
60 participants
Started: Jul 8, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03798678
CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
PHASE1Active, not recruiting
36 participants
Started: Jul 8, 2019 · Completed: Jan 30, 2026
2 conditions1 sponsor5 locations
NCT03546361
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
PHASE1Active, not recruiting
24 participants
Started: Jul 8, 2019 · Completed: Jan 11, 2027
4 conditions5 sponsors1 location
NCT03971955
CharacterIzation of Adult Onset Autoimmune Diabetes
N/AActive, not recruiting
25 participants
Started: Jul 8, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03879109
Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer
PHASE3Active, not recruiting
58 participants
Started: Jul 8, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor13 locations
NCT03794349
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
PHASE2Active, not recruiting
94 participants
Started: Jul 8, 2019 · Completed: Apr 7, 2026
3 conditions2 sponsors146 locations
NCT04090762
Improving Perinatal Outcomes Using Conditional and Targeted Transfers
NAActive, not recruiting
36,607 participants
Started: Jul 8, 2019 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT04034498
A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects
N/AActive, not recruiting
50 participants
Started: Jul 7, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor5 locations
NCT03918655
MIF Involvement in AML
N/AActive, not recruiting
186 participants
Started: Jul 7, 2019 · Completed: Jun 30, 2025
1 condition4 sponsors1 location
NCT03845712
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency
PHASE2Active, not recruiting
47 participants
Started: Jul 5, 2019 · Completed: Feb 19, 2026
1 condition1 sponsor8 locations
NCT03813836
Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC
PHASE2Active, not recruiting
63 participants
Started: Jul 5, 2019 · Completed: Jan 31, 2026
2 conditions2 sponsors12 locations
NCT04016376
Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction
PHASE4Active, not recruiting
1,507 participants
Started: Jul 5, 2019 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT04399642
Intra-articular Vancomycin Powder in Knee and Hip Arthroplasty
NAActive, not recruiting
1,832 participants
Started: Jul 5, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04003857
Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
PHASE2Active, not recruiting
60 participants
Started: Jul 5, 2019 · Completed: Jun 30, 2027
2 conditions1 sponsor2 locations
NCT03978000
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
PHASE3Active, not recruiting
2,158 participants
Started: Jul 4, 2019 · Completed: Jul 31, 2024
1 condition1 sponsor89 locations
NCT03878446
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
PHASE2Active, not recruiting
62 participants
Started: Jul 4, 2019 · Completed: Dec 23, 2026
1 condition1 sponsor52 locations
NCT03418779
Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD
PHASE2/PHASE3Active, not recruiting
60 participants
Started: Jul 4, 2019 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04001777
A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients
PHASE1Active, not recruiting
80 participants
Started: Jul 4, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors4 locations
NCT03784248
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
N/AActive, not recruiting
1,400 participants
Started: Jul 3, 2019 · Completed: Aug 15, 2025
1 condition1 sponsor1 location
NCT03914625
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
PHASE3Active, not recruiting
6,720 participants
Started: Jul 3, 2019 · Completed: Sep 30, 2027
3 conditions1 sponsor228 locations
NCT03942224
Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
PHASE2Active, not recruiting
49 participants
Started: Jul 3, 2019 · Completed: Jul 31, 2026
1 condition5 sponsors1 location
NCT04023747
Oxford Pre-cancerous Lymphoproliferative Disorders Study
N/AActive, not recruiting
574 participants
Started: Jul 3, 2019 · Completed: Oct 31, 2025
1 condition2 sponsors17 locations
NCT03863132
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
NAActive, not recruiting
120 participants
Started: Jul 3, 2019 · Completed: Mar 1, 2028
1 condition3 sponsors1 location